INTRODUCTION
Malignant pleural mesothelioma (MPM) is a rare but highly aggressive tumor that arises from the mesothelial surfaces of the pleura 1 . A causative link has been established between exposure to asbestos fibres and the subsequent development of MPM in 85% of subjects, while simultaneous infection with SV40 virus is also believed to contribute to MPM etiology 2 . MPM is often detected decades after initial exposure to the carcinogen; however, there is also a genetic contribution that predisposes individuals to developing this malignancy 3 . MPM is invariably terminal and histological sub-typing is currently the most important prognostic indicator of post diagnosis survival time 4 . Patients diagnosed with epithelioid MPM have a mean post diagnosis survival period of 16.3 months, while patients with sarcomatoid or biphasic MPM have a poorer prognosis with mean post diagnosis survival times of 6.1 months and 9.5 months respectively 5 . The estimation of prognosis based solely on histological typing is imprecise since up to 70% of all MPM cases are of epithelioidtype and considerable variation occurs in the actual survival times for patients within this subgroup. Additional prognostic markers are required in order to further sub-type MPM cases and so more effectively refine patient treatment regimes.
Female gender is a positive prognostic factor in MPM survival [5] [6] [7] , and this protection is at least partially mediated through the action of estrogen receptor beta (ERβ) 8 . ERmediated transcription initiation occurs when ligand-bound ER interacts with gene promoter sequences and recruits steroid receptor coactivators (SRCs) to promote the formation of the transcription pre-initiation complex 9 . The p160 family of coactivator proteins make a rate-limiting contribution to the formation of this complex and so rigidly control transcriptional responses stimulated by all steroid hormones. The p160
family is comprised of steroid receptor coactivator-1 (SRC-1/NCoA-1) 10 , transcriptional intermediary factor 2 (TIF-2/SRC-2/GRIP-1/NCoA-2) 11 and amplified in breast cancer-1 (AIB-1/SRC-3/NCoA-3) 12 . Dysregulation of p160 SRC expression affects tumour cell proliferation and invasive capacity; this occurs in all steroidsensitive malignancies including prostate carcinoma 13 and endometrial carcinoma 12 .
The contribution of SRCs to tumorigenesis is best characterized in the context of breast carcinoma where AIB-1 is defined by its up-regulation in the most aggressive tumors 12 and confirmed by the observation that AIB-1 over-expression in a mouse model resulted in the spontaneous generation of mammary tumors 14 .
The overall effect of estrogen action on tumor cell biology is complex, particularly in tissues that express both ERα and ERβ
15
. There is growing evidence of a protective role for ERβ expression and activation in some malignancies, including colorectal carcinoma 16 and MPM Primary antibodies were revealed using the Leica Bond Polymer Refine detection kit and the signal was enhanced using the Leica BondMax DAB enhancer kit. Slides were counterstained with haematoxylin before mounting and microscopic visualization.
MATERIALS and METHODS

Patients and Tissue Samples
Scoring System
Semi-quantitative determination of SRC-1, TIF-2, AIB-1 and ERβ was performed according to the criteria described by Allred et al.
18
. The proportion of positive stained cells was rated as 0 = no cells stained positive, 1 = between 0% and 1% positive, 2 = between 1% and 10%, 3 = between 10% and 33%, 4 = between 33% and 66%, and 5 = between 66% and 100%. In addition to the proportion score, an intensity score was made on the basis of the average intensity of staining: 0 = negative, 1 = weak, 2 = intermediate and 3 = strong. The proportion score and the intensity score were added to obtain the total score, and is either 0 or between 2 and 8. Allred scores of 6 or greater were interpreted as strong staining. Slides were independently evaluated and scored in a blind fashion by two independent observers. Any discrepancies in scoring between the observers were resolved by review of the slides under a doubleheaded microscope and a consensus score was allocated.
Statistical Analysis
Differences in post diagnosis survival were calculated using Kaplan-Meier analysis and survival curves were generated using the TMA Foresight package (TMA Foresight 3.01, Premier Biosoft International, Palo Alto, CA). P-values were calculated using a log-rank test 19 and a P-value <0.05 was taken to be indicative of statistical significance between populations. The multivariate Cox proportional hazard regression model was then used to calculate hazard ratios and to stratify the variables for known clinical parameters 20 . This ensures that the prognostic markers are independent of known clinical parameters (gender, tumor histological-type, age at diagnosis and chemotherapeutic intervention). All calculations were performed using the survival library of the open source R package (http://cran.r-project.org/) and the two-tailed Wald test was applied.
RESULTS
Patient Cohort Characteristics
SRC isoform and ERβ expression was determined using IHC in tumor biopsy specimens for a well-defined cohort of MPM subjects with >5 years post diagnosis follow-up. Paraffin embedded tumor tissue samples from 89 patients with age range 44 to 82 years (clinicopathological characteristics shown in Table 1 ) and 3 normal control subjects were analysed. The gender distribution of the MPM cohort was 73 male and 16 female subjects; the median age at diagnosis was 64 years for male and 65 years for female subjects. Histological types were determined to be 71 (79.8 %) epithelioid, 10 (11.2 %) biphasic and 8 (9.0 %) sarcomatoid. The majority of the subjects (n=64) had received cisplatin-based chemotherapy post diagnosis. Overall post-diagnosis Kaplan-Meier survival curves for histological-type and gender are shown (Fig 1) . The median post-diagnosis survival time was 15 months for patients with epithelioid MPM, 10 months for subjects with biphasic mesothelioma and 6 months for subjects with sarcomatoid mesothelioma (Fig 1.A) . The median survival time for male subjects was 10 months and 18 months for female subjects (Fig 1.B) .
These survival data show that the MPM subjects in this present study have equivalent distribution and outcomes when compared with MPM subject cohorts from other studies in which patients with the epithelioid-type mesothelioma have better prognosis, followed by patients with biphasic mesothelioma, while patients with sarcomatoid mesothelioma have the worst prognosis 5, 7 . Previous studies have also found a gender dichotomy in patient outcome, with improved survival for female MPM Comparative SRC expression in a MPM patient cohort has not previously been investigated. Here we found predominantly nuclear staining for each of the p160
SRCs: SRC-1 and AIB-1 (Supplemental Figure 1) , TIF-2 and also ERβ ( (Fig. 2) . The Allred scoring system was applied to quantify staining in each of the tumor samples for the three p160 SRCs and ERβ ( 
TIF-2 Expression and Prognosis in Epithelioid and Male Only Subgroups
Histological type and gender influence post diagnosis survival in MPM. Epithelioid histological type is a positive prognostic factor in MPM, while male gender is a negative prognostic factor. To determine if TIF-2 expression was of prognostic value when the outcome for epithelioid histology-type or for male subjects were analysed separately, Kaplan-Meier survival curves were calculated for high versus intermediate/ low TIF-2 expression in the tumors of subjects within these two subgroups. Median survival for subjects with epithelioid tumors (n = 71) that expressed high levels of TIF-2 was 23 months, while for those subjects with low or intermediate levels of TIF-2 expression had a median survival time of 9 months (P = 0.031, log-rank test) (Fig 3B) . Median survival of male patients (n = 73) with high TIF-2 expression levels was 20 months compared to 8 months for male patients with low or intermediate levels of TIF-2 expression (P = 0.003, log-rank test) (Fig 3C) .
Hazard Ratio
Multivariate Cox proportional hazard regression analysis was performed correcting for gender (male, female); age at diagnosis (<60, 60-69, ≥70 years); histological type (epithelioid, biphasic sarcomatoid) and chemotherapeutic intervention (therapy, no therapy) ( Table 3 , and consequently the molecular machinery of ER-regulated transcription is recruited to tumor suppression rather than promotion.
The anti-tumor action of estrogens is transduced through ERβ which regulates the expression of cell cycle regulators such as cyclin D1 8, 23 .
The strong dependency of ER transcriptional activity on SRC abundance led to our investigation of p160 SRC isoform expression in MPM tumors. Our study found that each of the p160 SRCs investigated: SRC1; TIF-2 and AIB-1 were highly expressed in normal pleural mesothelium from malignancy-free subjects, this novel observation 
Figure 4
Kaplan-Meier survival curve for malignant pleural mesothelioma subject survival discriminated by high versus low/ intermediate ERβ expression for the whole subject cohort.
Supplemental Figures
Supplemental Figure 1 Representative immuno-histochemical staining (x200 magnification) for SRC-1 (A-E), and AIB-1 (F-J) in normal pleural mesothelium (NM) and malignant pleural mesothelioma tumor tissue with Allred score (AS) values of 2, 4, 6 and 8.
Supplemental Figure 2
Kaplan-Meier survival curves for malignant pleural mesothelioma subject survival discriminated by high versus low SRC-1 expression (A) and high versus low AIB-1 expression (B). 
